Nexturn Bio Science Exercises Mirae Industries Conversion Rights to Demonstrate Commitment to Responsible Management

Nexturn Bio Science announced on April 30 that it has exercised its convertible bond (CB) conversion rights in Mirae Industries as a demonstration of its commitment to responsible management.

Mirae Industries, a company specializing in semiconductor back-end processes, also announced on the same day that conversion rights for convertible bonds worth 6 billion KRW have been exercised.

This amount was held by Nexturn Bio Science, the largest shareholder. The company explained that with the largest shareholder exercising the conversion rights of the convertible bonds, it will be able to accelerate improvements in its financial structure.

A representative from Nexturn Bio Science stated, "Through this conversion, all shares held will be subject to the capital reduction in line with Mirae Industries' capital reduction schedule, just like those of general shareholders. As the largest shareholder, we aim to strengthen our management rights and demonstrate our commitment to responsible management, and we will continue to work towards enhancing shareholder value."

Meanwhile, Nexturn Bio Science has several major subsidiaries, including EV Advanced Materials, which is listed on KOSDAQ; Mirae Industries, listed on KOSPI; and Roll Korea, an unlisted company.

This content was produced with the assistance of AI translation services.